Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
September 20, 2023 08:30 ET
|
Elutia Inc.
SILVER SPRING, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President...
Elutia Announces Private Placement for Proceeds Up to $26 Million
September 19, 2023 08:36 ET
|
Elutia Inc.
– Combined proceeds of financing and Orthobiologics divestiture potentially top $60 million – SILVER SPRING, Md., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company...
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
September 18, 2023 16:08 ET
|
Elutia Inc.
– Transaction Reflects Increasing Strategic Focus on Proprietary Drug-Eluting Biomatrix Platform – SILVER SPRING, Md., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a...
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 08, 2023 08:30 ET
|
Elutia Inc.
SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President...
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
September 06, 2023 16:05 ET
|
Elutia Inc.
– Company to begin trading under new ticker symbol “ELUT” – SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a change of the...
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
August 30, 2023 08:30 ET
|
Aziyo Biologics
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket SILVER SPRING, Md.,...
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
August 14, 2023 16:05 ET
|
Aziyo Biologics
Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up 32% year-over-year Successful transfer of...
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
July 31, 2023 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
July 13, 2023 16:30 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 13, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products to improve compatibility between medical...
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
May 19, 2023 08:15 ET
|
Aziyo Biologics
Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Aziyo...